Spectrum Pharmaceuticals, Inc. (SPPI)
-NasdaqGS 8.05 
0.09(1.09%) 4:00PM EDT|After Hours
:
8.12 0.07 (0.88%) 4:01PM EDT
| Prev Close: | 8.14 |
|---|
| Open: | 8.15 |
|---|
| Bid: | 8.02 x 700 |
|---|
| Ask: | 8.25 x 100 |
|---|
| 1y Target Est: | 11.38 |
|---|
| Beta: | 1.9 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 8.01 - 8.16 |
|---|
| 52wk Range: | 6.92 - 17.48 |
|---|
| Volume: | 673,643 |
|---|
| Avg Vol (3m): | 1,469,610 |
|---|
| Market Cap: | 476.47M |
|---|
| P/E (ttm): | 11.28 |
|---|
| EPS (ttm): | 0.71 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Outlook for the Most Shorted Stocksat Motley Fool(Fri, May 17)
- SPECTRUM PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Fri, May 17)
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharmaat TheStreet(Fri, May 17)
- The 5 Dumbest Things on Wall Street This Week: May 17at TheStreet(Fri, May 17)
- [video] 5 Dumbest Things on Wall Streetat TheStreet(Fri, May 17)
- Spectrum Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)at Seeking Alpha(Tue, May 14)
- Spectrum Pharma Reports 1Q LossZacks(Tue, May 14)
- 4 Obscure Healthcare Stocks To Watch In 2013at Seeking Alpha(Mon, May 13)
- SEC Is Investigating Spectrum Pharmaat TheStreet(Mon, May 13)
- Spectrum Pharmaceuticals to Present Corporate Update at the UBS Global Healthcare Conference in New York City on May 20thBusiness Wire(Mon, May 13)
- 3 Investment Strategy Lessons From Vertex's Successat Motley Fool(Sat, May 11)
- 5 Stocks Poised to Break Outat TheStreet(Fri, May 10)
- Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas on May 14thBusiness Wire(Fri, May 10)
- Spectrum Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 9)
- Q1 2013 Spectrum Pharmaceuticals Inc Earnings Release - Before Market OpenCCBN(Thu, May 9)
Key Statistics
| Forward P/E (1 yr): | 47.36 |
|---|
| P/S (ttm): | 1.95 |
|---|
| Ex-Dividend Date: | 18-Dec-12 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.17 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.12 |
|---|
| Mean Recommendation*: | 2.8 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Spectrum Pharmaceuticals, Inc., a biotechnology company, engages in acquiring, developing, and commercializing prescription drug products primarily in the areas of hematology and oncology.
View More